4//SEC Filing
Sagent Pharmaceuticals, Inc. 4
Accession 0001181431-14-009951
CIK 0001369786operating
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 5:06 PM ET
Size
5.7 KB
Accession
0001181431-14-009951
Insider Transaction Report
Form 4
Logerfo Michael
Chief Legal Officer
Transactions
- Sale
Common Stock
2014-02-27$21.43/sh−2,021$43,310→ 33,011 total
Holdings
- 1,000(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.36 to $21.54, inclusive.
- [F2]Shares held by a member of Mr. Logerfo's immediate family sharing the same household. Mr. Logerfo disclaims beneficial ownership of such shares.
Documents
Issuer
Sagent Pharmaceuticals, Inc.
CIK 0001369786
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369786
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 5:06 PM ET
- Size
- 5.7 KB